Patents on drugs worth over USD 200 billion are going to expire in the next 5-years, according to a study conducted by Heckyl. More than 330 drugs will lose patents issued by the US Patent and Trademark Office during CY2018-2022. These drugs constitute ~38.5% of the total number of patented drugs in the US.
A slew of impending patent expirations in the US offers a huge opportunity for generic drug manufacturers. The key beneficiaries of upcoming patent expiries are Mylan, Teva, Celgene, Wockhardt, Dr Reddy’s, Cipla, Lupin, Aurobindo, Natco and Cadila.
The UK new passenger vehicle sales data has shown a decline in recent months. Conversely, European new passenger vehicle sales continue its upward trajectory. The downward trend in UK sales is the first in five years.
The UK passenger vehicle sales’ 12-month moving sum for June 2017 and July 2017 fell below the previous year’s same period unit sales level for the first time in the last 5-years.
UK Passenger Vehicle Sales